ArticleJournal of hematology & oncology2018

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors.

Cathy Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.